Latest KFF Health News Stories
Some Thyroid Cancer Patients Can Safely Delay Surgery
Study suggests that many small tumors are sleepy, not deadly.
Pioneering Cancer Gene Therapy Gets Green Light — And $475,000 Price Tag
The USA’s first approved gene therapy — to be used to fight leukemia that resists standard therapies — will cost $475,000 for a one-time treatment.
Cáncer: cuando escribir ayuda a sanar
A través de la escritura expresiva, pacientes con cáncer logran canalizar sus miedos y ansiedades, y contar sus historias, en un inédito proceso creativo.
Writing Your Way Through Cancer
A breast cancer survivor and author has helped numerous patients explore the feelings awakened by their disease — and feel better.
Nueva droga contra la leucemia ofrece esperanza, pero a un costo millonario
El tratamiento con una nueva droga del laboratorio Novartis para casos en los que ha fracasado la quimioterapia o el trasplante de médula costaría $649,000.
‘Breakthrough’ Leukemia Drug Also Portends ‘Quantum Leap’ In Cost
A genetically altered cancer drug, based on CAR T-cell therapies, could be a big success with leukemia patients but at a staggering cost.
Colon Cancer Rates Rising Among Younger White Adults — And Falling Among Blacks
Although deaths from colorectal cancer are declining, researchers find rates of the disease among white men and women younger than 55 have spiked since the mid-1990s.
Safe Under The ACA, Patients With Preexisting Conditions Now Fear Bias
Thinking they were protected from insurance discrimination, many people got tested to see if they were likely to develop serious diseases. Legislation pushed by Republican leaders in Congress would leave them vulnerable.
Seniors Miss Out On Clinical Trials
Among hurdles: Older adults may have multiple illnesses that could complicate research or they might be unable to manage the commute.
Take Our Quiz To Test Your Wits On Aging
As we get older, it helps to tickle the noggin with trivia. Here’s a pop quiz to see what you have learned as a regular reader of Kaiser Health News.
“¿Cuánto tiempo me queda, doctor?” Por qué muchos pacientes con cáncer no obtienen respuestas
Muchas veces los pacientes con cáncer no reciben respuestas adecuadas a preguntas críticas, entre ellas, la más crucial y universal de todas.
‘How Long Have I Got, Doc?’ Why Many Cancer Patients Don’t Have Answers
Due to poor doctor-patient communication, most people with advanced cancer don’t know enough about their disease to make vital decisions.
As Government-Funded Cancer Research Sags, Scientists Fear U.S. Is ‘Losing Its Edge’
More of the research studies being presented at the world’s largest annual gathering of cancer scientists comes from abroad.
Quiz: Help Us Take The Pulse Of Our Readers
Even the most exalted among us realize health care policy is complicated. Here’s a pop quiz to see what you have learned as a regular reader of Kaiser Health News.
Urgent Care Sites Cater To Cancer Patients, Letting Them Check Some Worries At Door
Hospitals and oncology practices are setting up urgent care services aimed specifically at cancer patients to help keep them out of the hospital.
Widespread Hype Gives False Hope To Many Cancer Patients
Doctors and drug developers have a stake in making cancer treatments seem better than they really are.
Sticker Shock Forces Thousands Of Cancer Patients To Skip Drugs, Skimp On Treatment
A growing number of patients fail to fill prescriptions because the cost of cancer drugs is too high.
Cancer Rates Dropped During The Recession. That’s Not Necessarily A Good Thing.
Researchers believe Californians, many of whom lost health coverage, delayed doctor visits that could have led to earlier detection. Now, with people seeking medical care under the Affordable Care Act, some experts expect to see an increase in late-stage cancers.
Despite Prevention Guidelines, Few Smokers Seek CT Scans To Check For Lung Cancer
Lung cancer screening rates have not changed much even though the U.S. Preventive Services Task Force has recommended that smokers get checked, according to a new study.
Dozens Of New Cancer Drugs Do Little To Improve Survival, Frustrating Patients
The FDA has approved dozens of new cancer medications in recent years, but few offer the benefits that patients seek.
